(Q39599536)

13 September 2017

title

Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug (English)

1 reference

13 September 2017

1 reference

Sichao Huang

1

1 reference

13 September 2017

Rui Fang

2

1 reference

13 September 2017

Jun Xu

3

1 reference

13 September 2017

Shenghong Qiu

4

1 reference

13 September 2017

Huan Zhang

5

1 reference

13 September 2017

Jun Du

6

1 reference

13 September 2017

Shaohui Cai

7

1 reference

13 September 2017

publication date

2 February 2011

1 reference

Journal of Drug Targeting

13 September 2017

published in

1 reference

13 September 2017

volume

19

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

487-496

1 reference

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Tumour endoproteases: the cutting edge of cancer drug delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Doxorubicin: the good, the bad and the ugly effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Seprase complexes in cellular invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Purification, identification and characterisation of seprase from bovine serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Prodrug strategies in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Proteolysis: a biological process adapted in drug delivery, therapy, and imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

The structure and function of CD26 in the T-cell immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Friends or foes - bipolar effects of the tumour stroma in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Design of selectively activated anticancer prodrugs: elimination and cyclization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Enzyme-catalyzed activation of anticancer prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Stromal cells can contribute oncogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.511225

10.3109/1061186X.2010.511225

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference